IP Library Granted Patent US 9,175,165
Granted Patent B2
US 9,175,165 · App. 13/997,963 · Granted Nov 3, 2015

Chemosensors for hydrogen sulfide

Inventors: Hanjing Peng (Chamblee, GA); Binghe Wang (Marietta, GA)
Assignee: Georgia State University Research Foundation, Inc.
C09B56/20G01N21/64G01N21/643G01N31/22G01N33/0044Y10T436/184
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,175,165
App. No.
13/997,963
Granted
Nov 3, 2015
Kind
B2
Abstract

Selective chemosensing agents for hydrogen sulfide are provided. The chemosensing agents can act fast under mild conditions, are chemically stable for long-term storage, are sensitive for detection under near physiological conditions, show a linear concentration-signal relationship within physiologically relevant hydrogen sulfide concentration ranges for easy quantitation, show minimal or no interference by other anions in the blood, and are functional in aqueous solutions and blood plasma.

Claims (30)

1. A method of detecting hydrogen sulfide in a sample comprising contacting the sample with a chemosensing agent comprising an azide, wherein the chemosensing agent is represented by the following formula:

wherein

F is a fluorophore; and

wherein the azide of the chemosensing agent is reduced by the hydrogen sulfide and the reduction of the azide elicits a change in the maximum emission wavelength of the chemosensing agent, the fluorescence quantum yield of the chemosensing agent, the shape of the emission spectra of the chemosensing agent, the fluorescence lifetime of the chemosensing agent, and combinations thereof.

2. The method of claim 1 , wherein the fluorophore is selected from the group consisting of xanthene, xanthene derivatives, cyanine, cyanine derivatives, naphthalene, naphthalene derivatives, coumarin, coumarin derivatives, oxadiazole derivatives, pyrene, pyrene derivatives, oxazine derivatives, acridine, acridine derivatives, arylmethine derivatives, tetrapyrrole derivatives, fluorene, and fluorene derivative.

3. The method of claim 2 , wherein the fluorophore is naphthalene or a naphthalene derivative.

4. The method of claim 1 , wherein the chemosensing agent is defined by Formula I

wherein

R 1 and R 2 are, independently, hydrogen, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group; or

R 1 and R 2 , together with the nitrogen atom to which they are attached, forms a 4- to 8-membered hetercyclic ring.

5. The method of claim 4 , wherein R 1 and R 2 are both alkyl groups.

6. The method of claim 4 , wherein R 1 is a phenyl group and R 2 is hydrogen.

7. The method of claim 1 , wherein the chemosensing agent is defined by one of the following structures

8. The method of claim 1 , wherein the sample is an aqueous solution.

9. The method of claim 1 , wherein the sample is a biological sample.

10. The method of claim 9 , wherein the sample is a bodily fluid.

11. The method of claim 1 , further comprising measuring the fluorescence of the chemosensing agent.

12. The method of claim 1 , wherein the chemosensing agent reacts with the hydrogen sulfide without the addition of any additional reagents.

13. The method of claim 1 , wherein the limit of detection for hydrogen sulfide is less than 100 μM.

14. The method of claim 11 , wherein fluorescence intensity of the chemosensing agent, as measured at the maximum emission wavelength, reaches equilibrium less than ten minutes after contact with the hydrogen sulfide.

15. The method of claim 1 , wherein the chemosensing agent is immobilized on a solid support.

16. A chemosensing agent represented by the following formula:

wherein F is a fluorophore, wherein the fluorophore is selected from the group consisting of xanthene, xanthene derivatives, cyanine, cyanine derivatives, naphthalene, coumarin, coumarin derivatives, oxadiazole derivatives, pyrene, pyrene derivatives, oxazine derivatives, acridine, acridine derivatives, arylmethine derivatives, tetrapyrrole derivatives, fluorene, and fluorene derivatives.

17. A chemosensing agent represented by Formula I:

wherein,

(a) R 1 is hydrogen, a substituted or unsubstituted C 2 -C 30 alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group, and

R 2 is hydrogen, a substituted or unsubstituted C 1 -C 30 alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group; or

(b) R 1 and R 2 , together with the nitrogen atom to which they are attached, form a 4- to 8-membered hetercyclic ring.

18. The chemosensing agent of claim 17 , wherein R 1 and R 2 are both alkyl groups.

19. The chemosensing agent of claim 17 , wherein the chemosensing agent is defined by one of the following structures:

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 15, 2016
From: GEORGIA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039024/0456 →
Continuity (2)
Provisional Application 61430390 · Jan 6, 2011
Related Publication 20130302904A1 · Nov 14, 2013